Thus, activation of p38/MAPK kinases in response to sorafenib-induced stress might contribute to the resistant phenotype in HCC cells by enhancing mitochondrial biogenesis and function through multiple downstream targets, which may include nuclear and mitochondrial STAT3. Here, MAPK14 is linked to hepatocellular carcinoma.